|
⚲
|
| Nitric Biotherapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001460586 |
| Sale | 2009-03-31 ($2.2 M Offered, $1.7 M Sold) |
| Fund | |
| Phone | 2157886200 |
| Address | 2 Canals End Road Bristol, 19007 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Zev Scherl | |
| Richard Caruso | |
| Matthew Rieke | |
| Frank McCaney | |
| Hugh Macnaught | |
| Harold Chefitz |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Tg562 LLC
✚
|
0.0 | |
|
Vakil Arash
✚
|
0.0 | |
|
Verady LLC
✚
|
0.0 | |
|
Wilder Gary
✚
|
0.0 | |
|
Akadeum Life Sciences Inc
✚
|
0.0 | |
|
Grannus, LLC
✚
|
0.0 | |
|
HLM VM SPV LP
✚
|
0.0 | |
|
Lauro Jeffrey Alan
✚
|
0.0 | |
|
Lee Khim
✚
|
0.0 | |
|
Managed by Q Inc
✚
|
0.0 |